Barajas, Ana
Amengual-Rigo, Pep
Pons-Grífols, Anna
Ortiz, Raquel
Gracia Carmona, Oriol
Urrea, Victor
de la Iglesia, Nuria
Blanco-Heredia, Juan
Anjos-Souza, Carla
Varela, Ismael
Trinité, Benjamin
Tarrés-Freixas, Ferran
Rovirosa, Carla
Lepore, Rosalba
Vázquez, Miguel
de Mattos-Arruda, Leticia
Valencia, Alfonso
Clotet, Bonaventura
Aguilar-Gurrieri, Carmen http://orcid.org/0000-0002-5701-7650
Guallar, Victor
Carrillo, Jorge
Blanco, Julià
Funding for this research was provided by:
Departament de Salut, Generalitat de Catalunya (2021 SGR 00452)
Ministerio de Ciencia e Innovación (PID2019-106370RB-I00/AEI/10.13039/501100011033)
Secretaria d'Universitats i Recerca - Generalitat de Catalunya (2022FI_B00698)
Grifols
Sorigué
Article History
Received: 23 October 2023
Accepted: 28 December 2023
First Online: 3 January 2024
Declarations
:
: This study involves experimental procedures using mice. All experimental procedures were performed by trained researchers and approved by the competent authorities (Generalitat de Catalunya, Authorisation ID 9943). All experimental procedures were conducted in accordance with the Spanish laws and the Institutional Animal Care and Ethics Committee of the Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), and following the 3Rs principles.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Outside this work BC, JB and JC are founders and shareholders of AlbaJuna Therapeutics, S. L.